Researchers from Case Western Reserve University presented research today in which Hemex Health’s affordable Gazelle platform diagnostic technology successfully tested 46 patients with 100% sensitivity and over 92.3% specificity for anemia and with 100% accuracy for hemoglobin variants. The preliminary study included blood samples collected from Cleveland-area patients studied for anemia and sickle cell disease.
Read More
Integrated anemia-SCD test demonstrates accurate results in study at 2020 ASH meeting

Comments